Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ali İhsan Gemici"'
Autor:
Ali İhsan GEMİCİ, İstemi SERİN, Vedat Buğra EROL, Mehmet Hilmi DOĞU, İdris İNCE, Rafet EREN, Atakan TEKİNALP, Volkan KARAKUŞ, İklil Nur KOÇ EROL, Zeynep Ece ARSLAN, Zekiye Nur TAY, Elif Nur TUNCER, Ömür Gökmen SEVİNDİK
Publikováno v:
Forbes Tıp Dergisi, Vol 3, Iss 2, Pp 165-172 (2022)
Objective: Both the length of the treatment period and the diversity of the agents used in the treatment significantly affect the quality of life (QoL) of the patients with multiple myeloma (MM). With the aid of the EORTC Quality of Life Questionnair
Externí odkaz:
https://doaj.org/article/72d32f8ee7ef496cb5937c20070d45bb
Autor:
Ebru Erdoğan, Koray Yalçın, Cansu Hemşinlioğlu, Aslıhan Sezgin, Utku Seyis, Derya Dilek Kancağı, Cihan Taştan, Bulut Yurtsever, Raife Dilek Turan, Didem Çakırsoy, Selen Abanuz, Gözde Sır Karakuş, Muhammer Elek, Hüseyin Saffet Beköz, Ali İhsan Gemici, Deniz Sargın, Mutlu Arat, Burhan Ferhanoğlu, Ebru Pekgüç, Serdar Örnek, Deram Büyüktaş, Nur Birgen, Siret Ratip, Ercüment Ovalı
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 3, Pp 206-210 (2022)
Objective: Chimeric antigen receptor T (CAR-T) cell therapies have already made an impact on the treatment of B-cell malignancies. Although CAR-T cell therapies are promising, there are concerns about commercial products regarding their affordability
Externí odkaz:
https://doaj.org/article/556bd673500c45ae8473e751960454e8
Autor:
Cem Erdogan, Bahadir Ciftci, Deniz Kizilaslan, Mursel Ekinci, Gülsen İptec, Ali İhsan Gemici, Pelin Karaaslan
Publikováno v:
Ain Shams Journal of Anesthesiology, Vol 12, Iss 1, Pp 1-2 (2020)
Externí odkaz:
https://doaj.org/article/bc0eb85f10e843e1923cfab5370dab8e
Autor:
Sevil SADRİ, İpek YÖNAL HİNDİLERDEN, Yaşa Gül MUTLU, Tarık Onur TİRYAKİ, Ali İhsan GEMİCİ, Huseyin Saffet BEKOZ, Ömür GÖKMEN SEVİNDİK, Fehmi HİNDİLERDEN, Sevgi KALAYOĞLU-BEŞIŞIK, Meliha NALÇACI, Deniz SARGIN
Publikováno v:
The European Research Journal. :1-12
Objectives: The main objective of the present study was to evaluate whether the use of plerixafor in combination with granulocyte colony-stimulating factor (G-CSF) or subsequent use of isolated G-CSF and then plerixafor following disease-specific che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e6a378258126970b459742583031a36
https://doi.org/10.18621/eurj.1231251
https://doi.org/10.18621/eurj.1231251
Publikováno v:
Pneumon. 36:1-4
Localized tracheobronchial amyloidosis (TBA) is a rare form of pulmonary amyloidosis that is characterized by amyloidosis accumulation in the trachea and main bronchus submucosa. TBA is usually localized in the lung and is not associated with systemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03cc255cf0c7ff90c91d11d73b73a45b
https://doi.org/10.18332/pne/155919
https://doi.org/10.18332/pne/155919
Autor:
Ali İhsan Gemici, Özcan Çeneli, Furkan Selim Usta, Hatice Zeynep Dikici, Taha Ulutan Kars, Atakan Tekinalp, Sinan Demircioğlu
Publikováno v:
LLM Dergi. 5:5-10
Amaç: Çalışmamızın amacı, kısıtlamaların uygulandığı COVID-19 pandemi sürecinde hematoloji klinik işleyişinin değerlendirilmesidir. Hastalar ve Yöntem: Pandeminin ilk döneminde sokağa çıkma kısıtlamalarının uygulandığı 13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ddd1c3872b0f7b23c248bc826080681
https://doi.org/10.5578/llm.20219801
https://doi.org/10.5578/llm.20219801
Multipl miyelom tanılı hastalarda EORTC QLQ ile yaşam kalitesi değerlendirmesi: Çok merkezli çalışma
Autor:
Ali İhsan GEMİCİ, İstemi SERİN, Vedat Buğra EROL, Mehmet Hilmi DOĞU, İdris İNCE, Rafet EREN, Atakan TEKİNALP, Volkan KARAKUŞ, İklil Nur KOÇ EROL, Zeynep Ece ARSLAN, Zekiye Nur TAY, Elif Nur TUNCER, Ömür Gökmen SEVİNDİK
Objective: Both the length of the treatment period and the diversity of the agents used in the treatment significantly affect the quality of life (QoL) of the patients with multiple myeloma (MM). With the aid of the EORTC Quality of Life Questionnair
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6d037abc8b5c8ce0491f745ffcd1f67
https://hdl.handle.net/20.500.12511/10358
https://hdl.handle.net/20.500.12511/10358
Autor:
Mutlu Arat, Didem Cakirsoy, Selen Abanuz, Ercument Ovali, Bulut Yurtsever, Ali İhsan Gemici, Utku Seyis, Cansu Hemsinlioglu, Serdar Örnek, Gozde Sir Karakus, Huseyin Saffet Bekoz, Siret Ratip, Ebru Pekguc, Aslıhan Sezgin, Raife Dilek Turan, Koray Yalcin, Deniz Sargin, Muhammer Elek, Cihan Tastan, Deram Buyuktas, Burhan Ferhanoglu, Derya Dilek Kancagi, Nur Birgen, Ebru Erdogan
ObjectiveChimeric antigen receptor T (CAR-T) cell therapies already made an impact on the treatment of B cell malignancies. Although CAR-T cell therapies are promising, there are concerns with commercial products regarding their affordability and sus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::572ac870518042265443af4f71a3838d
https://doi.org/10.1101/2021.09.23.21263731
https://doi.org/10.1101/2021.09.23.21263731
Publikováno v:
Volume: 38, Issue: 2 167-171
Journal of Experimental and Clinical Medicine
Journal of Experimental and Clinical Medicine
Thromboembolism is a clinical finding that occurs due to thrombus; formed in the vascular system and has various etiological factors. It can be classified as central and peripheral thromboembolism. Our objective in this study is to explore genetic ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b267a09d22378c2a317978d29fdb5d2
https://hdl.handle.net/20.500.12511/6878
https://hdl.handle.net/20.500.12511/6878
Autor:
Mehmet Sinan Dal, Engin Kelkitli, Gulsum Akgun Cagliyan, Ali Ünal, Cengiz Demir, Fevzi Altuntaş, Serdar Sivgin, Ali İhsan Gemici, Rahsan Yildirim, Mehmet Yilmaz, Serdal Korkmaz, Olga Meltem Akay, Salih Aksu, Mehmet Hilmi Dogu, Hatice Terzi, Abdullah Karakuş, Vahap Okan, Mehmet Ali Erkurt, Deniz Goren Sahin, Bülent Eser, Kadir Ilkkilic, Orhan Ayyildiz, Muzaffer Keklik, Volkan Karakuş
Publikováno v:
Annals of hematology. 100(7)
WOS:000650535000001 PMID: 33988739 The aim of this study is to collect paroxysmal nocturnal hemoglobinuria (PNH) patient data from hematology centers all over Turkey in order to identify clinical features and management of PNH patients. Patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::328c7811ce07cc36fb08057b9f0d1bea
https://pubmed.ncbi.nlm.nih.gov/33988739
https://pubmed.ncbi.nlm.nih.gov/33988739